» Articles » PMID: 21952918

Evidence for Gene-gene Epistatic Interactions Among Susceptibility Loci for Systemic Lupus Erythematosus

Abstract

Objective: Several confirmed genetic susceptibility loci for lupus have been described. To date, no clear evidence for genetic epistasis in lupus has been established. The aim of this study was to test for gene-gene interactions in a number of known lupus susceptibility loci.

Methods: Eighteen single-nucleotide polymorphisms tagging independent and confirmed lupus susceptibility loci were genotyped in a set of 4,248 patients with lupus and 3,818 normal healthy control subjects of European descent. Epistasis was tested by a 2-step approach using both parametric and nonparametric methods. The false discovery rate (FDR) method was used to correct for multiple testing.

Results: We detected and confirmed gene-gene interactions between the HLA region and CTLA4, IRF5, and ITGAM and between PDCD1 and IL21 in patients with lupus. The most significant interaction detected by parametric analysis was between rs3131379 in the HLA region and rs231775 in CTLA4 (interaction odds ratio 1.19, Z = 3.95, P = 7.8 × 10(-5) [FDR ≤0.05], P for multifactor dimensionality reduction = 5.9 × 10(-45)). Importantly, our data suggest that in patients with lupus, the presence of the HLA lupus risk alleles in rs1270942 and rs3131379 increases the odds of also carrying the lupus risk allele in IRF5 (rs2070197) by 17% and 16%, respectively (P = 0.0028 and P = 0.0047, respectively).

Conclusion: We provide evidence for gene-gene epistasis in systemic lupus erythematosus. These findings support a role for genetic interaction contributing to the complexity of lupus heritability.

Citing Articles

Genetic interrogation for sequence and copy number variants in systemic lupus erythematosus.

Yeo N, Lim C, Yaung K, Khoo N, Arkachaisri T, Albani S Front Genet. 2024; 15:1341272.

PMID: 38501057 PMC: 10944961. DOI: 10.3389/fgene.2024.1341272.


Phenome-wide association study on miRNA-related sequence variants: the UK Biobank.

Mustafa R, Ghanbari M, Karhunen V, Evangelou M, Dehghan A Hum Genomics. 2023; 17(1):104.

PMID: 37996941 PMC: 10668386. DOI: 10.1186/s40246-023-00553-w.


HLA imputation and its application to genetic and molecular fine-mapping of the MHC region in autoimmune diseases.

Naito T, Okada Y Semin Immunopathol. 2021; 44(1):15-28.

PMID: 34786601 PMC: 8837514. DOI: 10.1007/s00281-021-00901-9.


Calcium-sensing receptor gene (CASR) polymorphisms and CASR transcript level concerning dyslipidemia in hemodialysis patients: a cross-sectional study.

Grzegorzewska A, Frycz B, Swiderska M, Niepolski L, Mostowska A, Jagodzinski P BMC Nephrol. 2019; 20(1):436.

PMID: 31775661 PMC: 6882244. DOI: 10.1186/s12882-019-1619-0.


Unravelling the Roles of Susceptibility Loci for Autoimmune Diseases in the Post-GWAS Era.

Ye J, Gillespie K, Rodriguez S Genes (Basel). 2018; 9(8).

PMID: 30060490 PMC: 6115971. DOI: 10.3390/genes9080377.


References
1.
Tian C, Hinds D, Shigeta R, Adler S, Lee A, Pahl M . A genomewide single-nucleotide-polymorphism panel for Mexican American admixture mapping. Am J Hum Genet. 2007; 80(6):1014-23. PMC: 1867091. DOI: 10.1086/513522. View

2.
Ritchie M, Hahn L, Roodi N, BAILEY L, Dupont W, Parl F . Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet. 2001; 69(1):138-47. PMC: 1226028. DOI: 10.1086/321276. View

3.
Cordell H . Detecting gene-gene interactions that underlie human diseases. Nat Rev Genet. 2009; 10(6):392-404. PMC: 2872761. DOI: 10.1038/nrg2579. View

4.
Lee Y, Rho Y, Choi S, Ji J, Song G, Nath S . The PTPN22 C1858T functional polymorphism and autoimmune diseases--a meta-analysis. Rheumatology (Oxford). 2006; 46(1):49-56. DOI: 10.1093/rheumatology/kel170. View

5.
Sanchez E, Webb R, Rasmussen A, Kelly J, Riba L, Kaufman K . Genetically determined Amerindian ancestry correlates with increased frequency of risk alleles for systemic lupus erythematosus. Arthritis Rheum. 2010; 62(12):3722-9. PMC: 3078084. DOI: 10.1002/art.27753. View